Prediction of Successful Ovarian Protection Using Gonadotropin-Releasing Hormone Agonists During Chemotherapy in Young Estrogen Receptor-Negative Breast Cancer Patients

Background: It is important to identify factors predicting successful ovarian protection using gonadotropin-releasing hormone (GnRH) agonists during chemotherapy. However, only a few studies have prospectively assessed this issue in young breast cancer patients. Objective: This study evaluated the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Dong-Yun, Kim, Ji-Yeon, Yu, Jonghan, Kim, Seok Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326007/
https://www.ncbi.nlm.nih.gov/pubmed/32656076
http://dx.doi.org/10.3389/fonc.2020.00863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326007/
https://www.ncbi.nlm.nih.gov/pubmed/32656076
http://dx.doi.org/10.3389/fonc.2020.00863

Ejemplares similares